Physician profile
Mark Mcomber
NPI 1790865103
$732.06
in general payments reported to CMS, 2019-2025
10 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.27 · 2021: $42.05 · 2022: $34.46 · 2023: $62.18 · 2024: $280 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587 · Education: $8.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.72 |
| Education | $8.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $288.32 | 2024-2025 | |
| Abbvie INC. | $107.67 | 2021-2025 | |
| Janssen Biotech, INC. | $96.86 | 2022-2025 | Tremfya |
| Qol Medical, LLC | $68.62 | 2019-2021 | |
| Alcresta Therapeutics, INC. | $57.81 | 2024-2025 | Relizorb |
| Medtronic, INC. | $29.64 | 2023 | Endoflip |
| Ironwood Pharmaceuticals, INC | $25.11 | 2024 | |
| Nestle Healthcare Nutrition INC. | $23.98 | 2023 | |
| Travere Therapeutics, INC. | $19.22 | 2019-2023 | Cholbam |
| Boston Scientific Corporation | $14.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mcomber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.